BioFuels Journal

Jupiter, FL — December 11, 2015 — Dyadic International, Inc. (OTCQX: DYAI) ("Dyadic") announced that at the special meeting of Dyadic shareholders held today, Dyadic's shareholders voted to approve the sale of substantially all of the enzyme and technology assets, including the C1 platform of Dyadic, Dyadic International (USA), Inc. ("Dyadic USA") and Dyadic Nederland B.V. to Danisco US Inc., a wholly-owned subsidiary of E. I. du Pont de Nemours and Company, ("Danisco") and its affiliate (the "Transaction") pursuant to the asset purchase and sale agreement, dated as of November 9, 2015, by and among Danisco, Dyadic USA and Dyadic (the "Transaction Agreement").

The affirmative vote of the holders of at least a majority of the shares of Dyadic common stock outstanding and entitled to vote thereon at the special meeting was required to approve the Transaction pursuant to the Transaction Agreement.

According to the final tally of shares voted, approximately 77% of the outstanding shares of Dyadic's common stock as of the close of business on the record date of November 13, 2015 were voted to approve the Transaction pursuant to the Transaction Agreement.

A quorum of approximately 78% of Dyadic's total outstanding shares of common stock as of the November 13, 2015 record date voted at the special meeting.

The proposed Transaction was announced on November 9, 2015 and is expected to close on December 31, 2015.

For more information, please contact Mark Emalfarb at 561-743-8333.

See Related Websites/Articles:

• Dyadic

more ETHANOL...